Tu1663 The Optimal Timing of Hepatitis C Therapy in Transplant Eligible Patients With Child B and C Cirrhosis: A Cost-Effectiveness Analysis

2016 ◽  
Vol 150 (4) ◽  
pp. S1161
Author(s):  
Elliot B. Tapper ◽  
Michael Hughes ◽  
Maria Buti ◽  
Jean-Francois Dufour ◽  
Steven Flamm ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Hepatitis C ◽  
Cost Effectiveness Analysis ◽  
Optimal Timing ◽  
Effectiveness Analysis ◽  
Hepatitis C Therapy

The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities

2018 ◽  
Vol 25 (7) ◽  
pp. 791-801 ◽  
Author(s):  
P. A. Cortesi ◽  
L. S. Belli ◽  
R. Facchetti ◽  
C. Mazzarelli ◽  
G. Perricone ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Hepatitis C ◽  
Liver Transplant ◽  
Cost Effectiveness Analysis ◽  
Optimal Timing ◽  
Effectiveness Analysis ◽  
Hepatitis C Therapy

scholarly journals Cost-Effectiveness Analysis Of Sofosbuvir For Genotype 2 Hepatitis C In Greece

2016 ◽  
Vol 19 (7) ◽  
pp. A415
Author(s):  
K Athanasakis ◽  
N Boubouchairopoulou ◽  
I Kyriopoulos ◽  
C Tsoulas ◽  
B Tzanakis ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Hepatitis C ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis ◽  
Genotype 2
Sign in / Sign up

Export Citation Format

Share Document